MET exon 14 Mutations Encode a Hyperactive Kinase and Therapeutic Target in Lung Adenocarcinoma

被引：0

作者：

Peled, Nir ^{[1
]}

Lu, Xinyuan ^{[2
]}

Greer, John ^{[2
]}

Wu, Wei ^{[2
]}

Choi, Peter ^{[3
]}

Berger, Alice ^{[3
]}

Hann, Byron ^{[2
]}

Meyerson, Matthew ^{[4
,5
]}

Collisson, Eric ^{[2
]}

机构：

[1] Rabin Med Ctr, Tel Aviv, Israel

[2] UCSF, San Francisco, CA USA

[3] Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA

[4] Broad Inst Harvard & Mit, Dana Farber Canc Inst, Boston, MA USA

[5] Massachusetts Gen Hosp, Boston, MA 02114 USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期

关键词：

MET; Resistance; Targeted therapy; Mouse model;

D O I：

10.1016/j.jtho.2016.11.1323

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2.03b042

引用

页码：S961 / S961

页数：1

共 50 条

[31] A never-smoker lung adenocarcinoma patient with a MET exon 14 mutation (D1028N) and a rapid partial response after crizotinib [J].

Linda Mahjoubi ;

Anas Gazzah ;

Benjamin Besse ;

Ludovic Lacroix ;

Jean-Charles Soria .

Investigational New Drugs, 2016, 34 :397-398

[32] Unfavorable response to capmatinib for MET exon14 skipping after first-line osimertinib in a patient with EGFR-mutated lung adenocarcinoma: A case report and literature review [J].

Araki, Taisuke ;

Kanda, Shintaro ;

Yazaki, Tatsuya ;

Hirabayashi, Taro ;

Komatsu, Masamichi ;

Sonehara, Kei ;

Tateishi, Kazunari ;

Hanaoka, Masayuki .

RESPIRATORY INVESTIGATION, 2024, 62 (04) :677-680

[33] A never-smoker lung adenocarcinoma patient with a MET exon 14 mutation (D1028N) and a rapid partial response after crizotinib [J].

Mahjoubi, Linda ;

Gazzah, Anas ;

Besse, Benjamin ;

Lacroix, Ludovic ;

Soria, Jean-Charles .

INVESTIGATIONAL NEW DRUGS, 2016, 34 (03) :397-398

[34] A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung Cancer [J].

Pruis, Melinda A. ;

Krebs, Matthew G. ;

Plummer, Ruth ;

De Vos, Filip ;

Angevin, Eric ;

Prenen, Hans ;

Forster, Martin D. ;

Clack, Glen ;

van der Aa, Annegret ;

Tjwa, Marc ;

Jansen, Ellen ;

Perera, Timothy ;

Lolkema, Martijn P. .

ONCOLOGIST, 2023, :e1248-e1258

[35] Calcium calmodulin dependent kinase kinase 2-a novel therapeutic target for gastric adenocarcinoma [J].

Subbannayya, Yashwanth ;

Syed, Nazia ;

Barbhuiya, Mustafa A. ;

Raja, Remya ;

Marimuthu, Arivusudar ;

Sahasrabuddhe, Nandini ;

Pinto, Sneha M. ;

Manda, Srikanth Srinivas ;

Renuse, Santosh ;

Manju, H. C. ;

Zameer, Mohammed Abdul Lateef ;

Sharma, Jyoti ;

Brait, Mariana ;

Srikumar, Kotteazeth ;

Carlos Roa, Juan ;

Kumar, M. Vijaya ;

Kumar, K. V. Veerendra ;

Prasad, T. S. Keshava ;

Ramaswamy, Girija ;

Kumar, Rekha Vijay ;

Pandey, Akhilesh ;

Gowda, Harsha ;

Chatterjee, Aditi .

CANCER BIOLOGY & THERAPY, 2015, 16 (02) :336-345

[36] An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples [J].

Bironzo, Paolo ;

Pepe, Francesco ;

Russo, Gianluca ;

Pisapia, Pasquale ;

Gragnano, Gianluca ;

Aquino, Gabriella ;

Bessi, Silvia ;

Buglioni, Simonetta ;

Bartoccini, Federico ;

Ferrero, Giuseppina ;

Bresciani, Michela Anna ;

di Celle, Paola Francia ;

Sibona, Francesca ;

Giusti, Andrea ;

Movilia, Alessandra ;

Farioli, Renata Mariella ;

Santoro, Alessandra ;

Salemi, Domenico ;

Scarpino, Stefania ;

Galafate, Dino ;

Tommasi, Stefania ;

Lacalamita, Rosanna ;

Seminati, Davide ;

Sajjadi, Elham ;

Novello, Silvia ;

Pagni, Fabio ;

Troncone, Giancarlo ;

Malapelle, Umberto .

DIAGNOSTICS, 2023, 13 (04)

[37] Neoadjuvant Savolitinib targeted therapy stage IIIA-N2 primary lung adenocarcinoma harboring MET Exon 14 skipping mutation: A case report [J].

Fu, Meng ;

Feng, Chun-Mei ;

Xia, Da-Qing ;

Ji, Zi-Mei ;

Xia, Huai-Ling ;

Hu, Na-Na ;

Leng, Zai-Jun ;

Xie, Wang ;

Fang, Yuan ;

Cao, Le-Jie ;

Zhang, Jun-Qiang .

FRONTIERS IN ONCOLOGY, 2022, 12

[38] Non-small cell lung cancer with MET exon 14 skip mutation: case report [J].

Clough, Wolfgang ;

Al Jaberi, Mira ;

Dalia, Samir .

ANNALS OF TRANSLATIONAL MEDICINE, 2022,

[39] Distinct MET Protein Localization Associated With MET Exon 14 Mutation Types in Patients With Non-small-cell Lung Cancer [J].

Qiu, Tian ;

Li, Weihua ;

Zhang, Tongtong ;

Xing, Puyuan ;

Huang, Wenting ;

Wang, Bingning ;

Chu, Lixia ;

Guo, Lei ;

Liu, Xiuyun ;

Li, Yan ;

Ying, Jianming ;

Li, Junling .

CLINICAL LUNG CANCER, 2018, 19 (04) :E391-E398

[40] MET exon 14 skipping mutations in non-small-cell lung cancer: real-world data from the Italian biomarker ATLAS database [J].

Reale, M. L. ;

Passiglia, F. ;

Cappuzzo, F. ;

Minuti, G. ;

Occhipinti, M. ;

Bulotta, A. ;

Delmonte, A. ;

Sini, C. ;

Galetta, D. ;

Roca, E. ;

Pelizzari, G. ;

Cortinovis, D. ;

Gariazzo, E. ;

Pilotto, S. ;

Citarella, F. ;

Bria, E. ;

Muscolino, P. ;

Pozzessere, D. ;

Carta, A. ;

Pignataro, D. ;

Calvetti, L. ;

Leone, F. ;

Banini, M. ;

Di Micco, C. ;

Baldini, E. ;

Favaretto, A. ;

Malapelle, U. ;

Novello, S. ;

Pasello, G. ;

Tiseo, M. .

ESMO OPEN, 2024, 9 (09)

← 1 2 3 4 5 →